

[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
Matthew Harrison Maintained (VRTX) at Hold with Increased Target to $253 on, Apr 19th, 2021
Matthew Harrison of Morgan Stanley, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Hold with Increased Target from $251 to $253 on, Apr 19th, 2021.
Matthew has made no other calls on VRTX in the last 4 months.
There are 6 other peers that have a rating on VRTX. Out of the 6 peers that are also analyzing VRTX, 1 agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Geoffrey Porges of "SVB Leerink" Maintained at Hold with Decreased Target to $250 on, Tuesday, February 2nd, 2021
These are the ratings of the 5 analyists that currently disagree with Matthew
- Brian Abrahams of "RBC Capital" Maintained at Buy and Held Target at $265 on, Friday, April 16th, 2021
- Brian Skorney of "Baird" Upgraded from Hold to Buy and Increased Target to $252 on, Tuesday, February 23rd, 2021
- Do Kim of "BMO Capital" Maintained at Buy with Decreased Target to $284 on, Tuesday, February 2nd, 2021
- Edward Tenthoff of "Piper Sandler" Maintained at Buy with Increased Target to $347 on, Tuesday, February 2nd, 2021
- Evan Seigerman of "Credit Suisse" Maintained at Buy with Decreased Target to $280 on, Tuesday, February 2nd, 2021
Contributing Sources